View More View Less
  • 1 Semmelweis Egyetem, Gyógyszerésztudományi Kar, Budapest, Üllői út 26., 1085
Open access

Absztrakt:

A hagyományos kínai orvoslás (HKO) terminológiája aligha értelmezhető az emberi genommal összefüggésben, ezért az emberigenom-program ismeretében a kínai orvoslás figyelme a nyugati orvoslásra irányult. Az elmúlt két évtizedben számos fontos lépést lehetett megfigyelni Kínában a hagyományos kínai és a nyugati orvoslás közelítésével. A kínai kormány támogatja adatbázisok kiépítését, annak érdekében, hogy tisztázzák a génkifejeződések, a jelátviteli utak, a fehérje–fehérje interakciók között lévő kapcsolatokat, és felderítsék a kínai gyógynövények bioaktív komponenseinek hatását ezekre a tényezőkre. A HKO értékei egyre fontosabbá válnak a nyugati orvoslás számára is, mert a molekuláris biológiai terápiák nem váltották be a hozzájuk fűzött reményeket. Orv Hetil. 2018; 159(18): 696–702.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Rapavi E, Blázovics A, Fehér J. The role of herbs in ancient Chinese medicine. [A gyógynövények szerepe az ősi Kína gyógyászatában.] Orv Hetil. 2000; 38: 2093–2096. [Hungarian]

  • 2

    Rapavi E, Blázovics A. Chinese herbal science in a nutshell. [Kínai gyógynövénytudomány dióhéjban.] Fitoterápia 2000; 5(1–2): 18–23. [Hungarian]

  • 3

    Cheng JT. Review: drug therapy in Chinese traditional medicine. J Clin Pharmacol. 2000; 40: 445–450.

  • 4

    Lu AP, Jia HW, Xiao C, et al. Theory of traditional Chinese medicine and therapeutic method of diseases. World J Gastroenterol. 2004; 10: 1854–1856.

  • 5

    Blanford YF. Discovery of lost eloquence: New insight from the Mawangdui ‘Zhanguo zonghengjia shu’. J Am Orient Soc. 1994; 114: 77–82.

  • 6

    Jiang M, Lu, MC, Zhang C, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol. 2012; 140: 634–642.

  • 7

    Ryu H, Lee H, Kim H, et al. Reliability and validity of a cold-heat pattern questionnaire for traditional Chinese medicine. J Altern Complement Med. 2010; 16: 663–667.

  • 8

    Song YN, Zhang GB, Zhang YY, et al. Clinical applications of omics technologies on ZHENG differentiation research in traditional Chinese medicine. Evid Based Complement Alternat Med. 2013; 2013: 989618; http://dx.doi.org/10.1155/2013/989618

  • 9

    Chen Z. Herbs of Chinese medicine in the 21st century. In: Blázovics A, Mézes M. (eds.) Natural bioactive ingredients in modern medicine. [A kínai gyógyászat gyógynövényei a XXI. században. In: Blázovics A, Mézes M. (szerk.) Természetes hatóanyagok a modern orvoslásban.] Szent István Egyetemi Kiadó, Gödöllő, 2013; pp. 18–22. [Hungarian]

  • 10

    Chi C, Lee JL, Lai JS, et al. The practice of Chinese medicine in Taiwan. Soc Sci Med. 1996; 43: 1329–1348.

  • 11

    Hu L, Lao SX, Tang CZ. Expression of bcl-2 oncogene in gastric precancerous lesions and its correlation with syndromes in traditional Chinese medicine. World J Gastroenterol. 2005; 11: 3293–3296.

  • 12

    Zhang C, Wang J, Liu G, et al. Effect of the Chinese traditional medicine “Bushen Yinao Pian” on the cerebral gene expression of the senescence-accelerated mouse prone 8/Ta. Am J Chin Med. 2005; 33: 639–650.

  • 13

    Hseu YC, Wu FY, Wu JJ, et al. Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway. Int Immunopharmacol. 2005; 5: 1914–1925.

  • 14

    Mu Y, Zhang J, Zhang S, et al. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther. 2006; 316: 1369–1377.

  • 15

    Zhou X., Peng Y., Liu B. Text mining for traditional Chinese medical knowledge discovery: a survey. J Biomed Informat. 2010; 43: 650–660.

  • 16

    Fan W. The traditional Chinese medical literature analysis and retrieval system (TCMLARS) and its application. Inspel 2001; 35: 147–156.

  • 17

    He M, Yan X, Zhou J, et al. Traditional Chinese medicine database and application on the Web. J Chem Inf Comput Sci. 2001; 41: 273–277.

  • 18

    Harmsworth K, Lewith GT. Attitudes to traditional Chinese medicine amongst Western trained doctors in the People’s Republic of China. Soc Sci Med. 2001; 52: 149–153.

  • 19

    Jiang M, Zhang C, Zheng G, et al. Traditional Chinese medicine Zheng in the era of evidence-based medicine: a literature analysis. Evid Based Complement Alternat Med. 2012; 2012: 409568.

  • 20

    Bensoussan A, Myers SP, Drew AK, et al. Development of a Chinese herbal medicine toxicology database. J Toxicol Clin Toxicol. 2002; 40: 159–167.

  • 21

    Xue R, Fang Z, Zhang M, et al. TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 2013; 1: 1089–1095.

  • 22

    Qiao X, Hou T, Zhang W, et al. A 3D structure database of components from Chinese traditional medicinal herbs. J Chem Inf Comput Sci. 2002; 42: 481–489.

  • 23

    Jiang Y, Li ZS, Jiang FS, et al. Effects of different ingredients of zedoary on gene expression of HSC-T6 cells. World J Gastroenterol. 2005; 11: 6780–6786.

  • 24

    Chen X, Zhou H, Liu YB, et al. Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation. Br J Pharmacol. 2006; 149: 1092–1103.

  • 25

    Fang YC, Huang HC, Chen HH, et al. TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining. BMC Complement Alter Med. 2008; 8: 58; http://www.biomedcentral.com/1472-6882/8/58

  • 26

    Huang XD, Kong LA, Li X, et al. Stategy for analysis and screening of bioactive compounds in traditional Chinese medicines. J Chromatogr. B 2004; 812: 71–84.

  • 27

    Yu YN, Liu J, Zhang L, et al. Clinical Zheng-hou Pharmacology: The missing link between pharmacogenomics and personalized medicine? Curr Vasc Pharmacol. 2015; 13: 423–432.

  • 28

    Li S, Zhang ZQ, Wu LJ, et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol. 2007, 1: 51–60.

  • 29

    Wang J, van der Heijden R, Spruit S, et al. Quality and safety of Chinese herbal medicines guided by a system biology perspective. J Ethnopharmacol. 2009; 126: 31–41.

  • 30

    Végner L, Peragovics Á, Tombor L, et al. Experimental confirmation of new drug–target interactions predicted by drug profile matching. J Med Chem. 2013; 56: 8377–8388.